Syfovre™ (pegcetacoplan) – New drug approval
February 17, 2023 - Apellis announced the FDA approval of Syfovre (pegcetacoplan) intravitreal injection, for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
Download PDF
